Initial Study on the Therapeutic Role of Moxifloxacin in Adult Mycoplasma Pneumonia
Abstract
【Objective】To study the therapeutic role of moxifloxacin in adult mycoplasma pneumonia.【Methods】The 20 case of adult mycoplasma pneumonia patient treated with moxifloxacin were retrospective reviewed,the therapeutic effect of moxifloxacin was investigated through the change of patient body temperature and thoracic CT scan.【Results】①On admission,the average body temperature of patients were: 38.50±0.86℃,on the 3 and 5 day after treatment with moxifloxacin,the average body temperature were 37.18±0.61℃ and 36.77±0.35℃ respectively,they were significantly decreased compare with the day of admission,respectively(P0.001, respectively).The temperature were also significantly decreased on the 5 day compare with the 3 day after treatment(P0.01).②The average stay were 13.56±3.96 days.③Therapeutic effect on thoracic CT imaging change in 13 patients: fully recovery were 5 cases(5/13),excellence were 6 cases(6/13),improvement were 2 cases(2/13) and inefficacy was 0.【Conclusion】It have better therapeutic effect in control the body temperature and thoracic CT imaging change that moxifloxacin inject to adult mycoplasma pneumonia patient via vein.
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.